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Abstract
Background: Long-term, low-level exposure to toxic elements in soil may be harmful to human health but large
longitudinal cohort studies with sufficient follow-up time to study these effects are cost-prohibitive and impractical.
Linkage of routinely collected medical outcome data to systematic surveys of soil quality may offer a viable alternative.
Methods: We used the Geochemical Baseline Survey of the Environment (G-BASE), a systematic X-ray fluorescence
survey of soil inorganic chemistry throughout England and Wales to obtain estimates of the concentrations of 15
elements in the soil contained within each English and Welsh postcode area. We linked these data to the residential
postcodes of individuals enrolled in The Health Improvement Network (THIN), a large database of UK primary care
medical records, to provide estimates of exposure. Observed exposure levels among the THIN population were
compared with expectations based on UK population estimates to assess representativeness.
Results: Three hundred seventy-seven of three hundred ninety-five English and Welsh THIN practices agreed to
participate in the linkage, providing complete residential soil metal estimates for 6,243,363 individuals (92% of all
current and former patients) with a mean period of prospective computerised medical data collection (follow-up)
of 6.75 years. Overall agreement between the THIN population and expectations was excellent; however, the number
of participating practices in the Yorkshire & Humber strategic health authority was low, leading to restricted ranges of
measurements for some elements relative to the known variations in geochemical concentrations in this area.
Conclusions: The linked database provides unprecedented population size and statistical power to study the effects of
elements in soil on human health. With appropriate adjustment, results should be generalizable to and representative
of the wider English and Welsh population.
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Background
Soil is a complex mixture of minerals, live and dead organic
matter, air, and water. The constituents of soils can enter
the human body directly via geophagy or unintentional soil
ingestion, airborne dust inhalation and absorption through
(or through breaks in) the skin, or indirectly via the food
chain (due to prior uptake by crop plants or consumption
by livestock). Previous research suggests that adults in
developed countries may inadvertently ingest between 23
and 625 mg of soil each day [1]. Soils ubiquitously contain
a range of inorganic elements produced through natural
soil-forming processes, and as a legacy of inputs from
human activity. Some, such as arsenic, cadmium, and lead,
have long been recognized as harmful to human health in
moderate to high doses [2], although the consequences of
long-term low-level exposure remain unclear.
Existing research into the health impacts of soil con-
stituents has tended to focus on geographic areas where
abnormally high levels of exposure are observed. Studies
of the effects of moderate or trace levels of potentially
toxic elements are constrained by the commensurately
smaller increases in the risk of adverse health outcomes
they may produce. Furthermore, some adverse effects
of soil contamination may only become apparent after
extended periods of time, even in the presence of high
levels of exposure. In consequence, it is often impractical
or prohibitively expensive to recruit a sufficiently large (and
statistically powerful) population of exposed individuals
and to monitor their health over a sufficiently long period
for such risks to become detectable.
For this reason, the safe maximum levels of many soil
contaminants are not known. Existing official limits are
typically based on backwards extrapolation from the known
effects of extreme exposures or on inferences drawn from
alternative sources of exposure [3].
The ability of epidemiological researchers to detect
rare adverse effects of prescribed medications, and to
study the causes of rare illnesses has been transformed
in recent years by the development of large databases of
routinely collected longitudinal data from United Kingdom
health care services [4]. The use of such databases permits
the construction of virtual study populations, with many
years of follow-up, from a pool of millions of individual
patients. The range of studies that can be carried out using
such databases can be broadened through the linkage of
individual patient records to other national data sources
based on National Health Service patient identification
numbers [5] or on patients’ home addresses [6].
In recent years, the British Geological Survey (BGS)
has carried out a comprehensive survey of the inorganic
geochemistry of soils throughout England and Wales. We
therefore carried out a linkage between these measurements
and the medical records of over 7 million current and
former patients from 377 primary care practices located
throughout England and Wales, based on individuals’ resi-
dential postcodes, creating a uniquely large and compre-
hensive database of soil exposures and health outcomes.
To assess the representativeness and generalizability of the
linked patient population, we carried out a validation com-
paring the range of exposures among our patients with
those that would be expected based on known population
distributions throughout the sampling area.
Methods
Data sources
BGS Geochemical Baseline Survey of the Environment (G-BASE)
The geochemical data used in this project derive from the
BGS systematic national Geochemical Baseline Survey
of the Environment (G-BASE) rural and urban soil
information [7–9] and from a BGS re-analysis of the
National Soil Inventory X-ray fluorescence spectrometry
(NSI(XRFS)) samples [10, 11].
The two projects are closely comparable in their methods
of collection: 0–15 cm deep with a sample support of 20 m
and subsequently dried at ~ 30 °C sieving to < 2 mm to
exclude stones. The most significant difference between
these surveys lies in the densities at which samples have
been collected and the extent to which these surveys cover
the land area of England and Wales. The rural G-BASE
(collected from 1968 to 2007) data are concentrated in
eastern and central England (Fig. 1) with additional samples
from the Tamar catchment of South West England, with
samples collected at 1 per 2 km2. Urban G-BASE samples
have been collected (from 1992 to date) from the centers
shown in Fig. 1 at a density of 4 per km2, making this the
highest density of samples available in this study and
the only systematic survey of urban soils in Britain. The
NSI(XRFS) samples were collected (initially in the 1980s,
with one-third of points resampled in the mid-1990s) at a
density of 1 per 25 km2 over the whole of England and
Wales and provide completeness of coverage of non-urban
land areas, albeit at a coarser resolution than the rural
G-BASE survey. These merged datasets give a total of
42,422 sample sites with data.
All of these data have been acquired by X-ray fluores-
cence spectrometry (XRFS) at the BGS laboratories using
reference materials that allow bias and precision of the
analyses to be monitored, providing a consistency and thus
comparability between methods across all three datasets:
we therefore jointly refer to these as G-BASE data in the
rest of this paper. The use of XRFS is a true total analysis,
as it requires no dissolution of the sample [12].
Data are available for 40 elements in total, and of these
15 were selected for linkage with the medical record
data on the basis that they are major elements in soil
(calcium, aluminium, and silicon), have a role to play in
mobility of trace elements (iron [13]) in soil or are trace
elements of key interest due to their known or suspected
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effects on human health (arsenic [14], chromium [15],
copper [16], lead [17], manganese [18], nickel [19],
phosphorus [20], selenium [21], uranium [22], vanadium
[23], and zinc [24]). We excluded cadmium from the final
selection, in spite of its known toxicity in humans [25],
because the concentrations observed in approximately
75% of G-BASE samples were below XRFS detection
limits. Maps showing the variations in concentrations of
the included elements throughout England and Wales are
available in Additional file 1.
The Health Improvement Network database
Each individual in the UK population has the right to
register with an NHS primary care practitioner who acts
as their first port of call for most non-emergency medical
assistance, providing onward referrals to secondary care
facilities as necessary. The primary care practitioner is
informed of diagnoses made and treatments given or
initiated by secondary care institutions as a matter of
routine. As a consequence of this gatekeeper role, the
primary care medical record provides a comprehensive
summary of each patient’s medical history and interactions
with the NHS.
The use of electronic medical record (EMR) software
packages to create, store, and maintain primary care
records has been widespread amongst UK practitioners
since the early 1990s and has effectively been mandatory
since the introduction in 2004 of the Quality and Outcomes
Framework [26], an NHS pay-for-performance scheme
which relies on analysis of EMRs to assess compliance with
a range of record-keeping and care quality targets. The
major EMR packages used by UK practitioners enable
offsite backup facilities via a secure electronic link with
the software provider.
These characteristics of UK EMR systems, and the rela-
tively small number of packages in use, have facilitated the
creation of several health research databases amalgamating
data from multiple clinics to create large patient popula-
tions. The Health Improvement Network database is one
such resource, containing the EMRs of over 10 million
patients registered at over 500 practices throughout
Great Britain and Northern Ireland, including 450 prac-
tices within the G-BASE coverage area. THIN has been
extensively used in epidemiological research and the
quality of recording has been validated for a wide range
of important health outcomes (see e.g., [27–34]).
Linkage process
In order to preserve patient confidentiality, EMRs in
THIN are stripped of details such as names, addresses, days
and months of birth, and the exact locations of participating
primary care practices prior to their transmission from the
practice computer to the THIN data warehouse. Linkage of
the G-BASE data to THIN records was therefore carried
out within the participating practices themselves.
The G-BASE sample results and sampling locations
were loaded into ArcGIS (Esri, Redlands, California, US)
and used to interpolate each substance, with an inverse
distance weighting (IDW) option with a search radius of
5 km and an output cell size of 1 km. Polygons defining
the English and Welsh postcode areas were overlaid, and
a summary value (calculated as the concentration inter-
secting the point of the postcode polygon centroid)
determined for each. Where there were no data within
the search region, the result was returned as a missing
value. Since there are more postcodes (1,526,890) than
sample sites, the distance from each postcode polygon
centroid to the nearest sample site was calculated to
establish the appropriateness of this method of joining the
two data sources. This showed that 50% of the postcode
centroids were < 1.3 km, and 97% of postcodes < 5 km,
from an original sample site. These distances are a close
match to the original sampling interval of the survey data
(Fig. 1) used to derive the IDW raster surface of concen-
tration values.
These data were output in text format and passed to
The Health Improvement Network. Practices falling within
Fig. 1 Map of G-BASE sample locations in England and Wales. Black
areas denote urban centres where samples are taken at a density of
4 per km2. Grey areas denote rural G-BASE areas, with a sampling
density of 1 per 2 km2. Grey dots indicate locations of NSI(XRFS)
samples, at an overall density of 1 per 25 km2. Red lines circumscribe
the English Strategic Health Authority catchment areas. Contains
Ordnance Survey data © Crown Copyright and database rights [2015]
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the G-BASE coverage area were contacted individually and
asked to participate in the linkage exercise. Where consent
was given, a copy of the data was uploaded to the practice
computer system via a secure electronic link, along with a
script to be run by the practice manager. The script
searched the G-BASE extract for the postcode of each
patient’s current (or last known, for deceased or dereg-
istered patients) residential address and, where a match
was found, transmitted the patient’s unique identification
code and the summary soil values (but, to preserve confi-
dentiality, not the postcode) back to THIN. The patient
identification codes were then used to link the soil values
to the anonymized EMRs in the main THIN database.
Validation
Whilst the exact locations of patients and practices in
THIN are unknown to us, the database does provide
information on the Strategic Health Authority (SHA) to
which each practice belongs. We therefore compared
the levels of residential exposure experienced by patients
registered in THIN with those that would be expected
based on known population distributions in each SHA
area.
Expected exposure distributions in each SHA were
obtained by first estimating the population of each post-
code area. The UK Office for National Statistics (ONS)
postcode directory, which gives details of the SHA and
census output area (OA) into which each postcode falls,
was linked to 2011 OA census populations from the UK
data service (formerly UKBorders) [35]. Each postcode
within an OA was assumed to contain an equal proportion
of the OA population. Where postcodes crossed an OA or
SHA border, the postcode was randomly assigned to a
single area.
The postcode-specific population estimates were then
linked to the postcode-specific soil values obtained pre-
viously, and boxplots describing the expected exposure
distributions in each SHA area were generated. Com-
parison boxplots were constructed describing exposures
among all THIN patients who were alive and actively
registered on the date of the 2011 census.
Results
Practice participation and patient coverage
At the time the data linkage process commenced, THIN
contained information from 450 primary care practices in
England and Wales. Of these, 395 were active contributors
to THIN at the time the linkage commenced, with the
remainder having left, merged, or closed at some point
prior. 377 (95%) of active practices agreed to participate in
the linkage. The participation rate among practices in each
SHA area is shown in Table 1. Participation was greatest
in the West Midlands and South Central SHAs (both
100%) and lowest in Yorkshire & Humber (78%). The
conspicuously low rate in the latter case in fact represents
only two refusals, the low percentage being a consequence
of the small number of THIN practices in this region.
At the time of the linkage, THIN contained the medical
records of 7.1 million patients currently or formerly
registered at the 395 actively contributing practices.
The average period of prospective computerized data
recording (follow-up) was 6.75 years. 6.8 million (96%)
of these patients were registered at a practice that
agreed to participate in the linkage. 6.3 million patients
(93%) from linkage practices lived in a postcode where
at least one soil element level could be obtained from
G-BASE, and 6.2 million patients (92%) lived in an area
where all 15 were available.
Of the patients with no soil measurements following
the linkage process, 144,600 lived in a postcode listed in
the postcode file uploaded to the practices, but for which
there was no G-BASE coverage. For the remainder, the
matching process failed entirely, indicating that the affected
patients either had no postcode recorded in their medical
records, an invalid or out-dated postcode, or a valid
postcode not listed in the file uploaded to the practices
(possibly because the postcode was newly-created).
Table 2 shows the matching levels broken down by
SHA. The percentages of patients registered at linkage
practices were similar to the percentages of practices
that participated in the linkage (Table 1) suggesting that
there was no marked difference in the sizes of the practices
that declined to take part. The matching process was most
successful in the East Midlands and the East of England,
with 96 and 97% of patients respectively having the
complete set of G-BASE measures, and least successful
Table 1 Number of practices participating in the linkage
between The Health Improvement Network database and the
Geological Baseline Survey of the Environment, by Strategic
Health Authority area
Strategic Health
Authority
Participating
practices
Active
practices
Participation rate (%)
East Midlands 12 13 92
East of England 26 30 87
London 59 61 97
North East 12 13 92
North West 52 54 96
South Central 47 47 100
South East Coast 41 43 95
South West 45 46 98
Wales 36 39 92
West Midlands 40 40 100
Yorkshire & Humber 7 9 78
Total 377 395 95
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in London and the North East (84% complete in both
cases.
The complete THIN database contains the details of
all patients for whom an EMR has ever been created at a
participating practice, even in cases where the patient
died or deregistered some time ago. In order to carry out a
like-for-like comparison between soil measurements in
THIN and expectations based on the population distribu-
tion at the time of the 2011 census, it was necessary to
restrict to patients alive and actively registered on this date.
Among these patients the matching process was more suc-
cessful, reflecting the increased likelihood that practitioners
will hold a correct, up-to-date postcode for current or
recent patients. 3.2 million patients were registered at
actively participating practices. 3.0 million (96%) were
registered at a linkage practice. Complete and partial
G-BASE measurements were available for 95% (2.9 million)
and 96% (2.9 million) of these patients respectively.
Sixty-six thousand three hundred twenty-seven patients
lived in an area with no G-BASE coverage and 62,054
patients could not be matched. Table 3 shows the match-
ing levels broken down by SHA. Again, the proportions of
patients matched were similar to practice participation
rates. The linkage was most successful in the East
Midlands and the East of England (almost 100% of patients
having complete G-BASE data in both areas), and weakest
in the North East (88% complete) and London (89%
complete).
Table 2 Proportions of all patients ever registered at practices actively contributing data to The Health Improvement for whom
partial (at least one element) or complete (all elements) soil measurements were obtained through linkage to the Geochemical
Baseline Survey of the Environment (G-BASE)
Strategic
Health Authority
Total patients at
active practices
Patients at linkage
practices (% of total)
Patients with partial G-BASE data
(% of patients at linkage practices)
Patients with complete G-BASE data
(% of patients at linkage practices)
East Midlands 212,395 198,085 (93.3%) 190,681 (96.3%) 190,679 (96.3%)
East of England 574,828 474,517 (82.5%) 462,008 (97.4%) 462,005 (97.4%)
London 1,208,044 1,190,099 (98.5%) 1,000,246 (84.0%) 1,000,232 (84.0%)
North East 218,821 208,238 (95.2%) 175,302 (84.2%) 175,301 (84.2%)
North West 767,722 733,446 (95.5%) 660,898 (90.1%) 656,475 (89.5%)
South Central 1,069,029 1,069,029 (100.0%) 1,040,055 (97.3%) 1,035,340 (96.8%)
South East Coast 873,765 845,650 (96.8%) 804,428 (95.1%) 804,367 (95.1%)
South West 763,658 752,735 (98.6%) 706,818 (93.9%) 706,817 (93.9%)
Wales 564,190 503,432 (89.2%) 485,619 (96.5%) 451,544 (89.7%)
West Midlands 716,592 716,592 (100.0%) 662,649 (92.5%) 633,347 (88.4%)
Yorkshire & Humber 168,321 133,559 (79.3%) 131,448 (98.4%) 127,256 (95.3%)
Total 7,137,365 6,825,382 (95.6%) 6,320,152 (92.6%) 6,243,363 (91.5%)
Table 3 Proportion of patients alive and registered on the date of the 2011 census at practices actively contributing data to The
Health Improvement Network for whom partial (at least one element) or complete (all elements) soil measurements were obtained
through linkage to the Geochemical Baseline Survey of the Environment (G-BASE)
Strategic
Health Authority
Total patients at
active practices
Patients at linkage
practices (% of total)
Patients with partial G-BASE data
(% of patients at linkage practices)
Patients with complete G-BASE data
(% of patients at linkage practices)
East Midlands 102,970 96,498 (93.7%) 96,448 (99.9%) 96,448 (99.9%)
East of England 262,070 219,216 (83.6%) 219,038 (99.9%) 219,038 (99.9%)
London 443,050 436,073 (98.4%) 388,973 (89.2%) 388,970 (89.2%)
North East 105,225 99,672 (94.7%) 87,656 (87.9%) 87,656 (87.9%)
North West 375,752 361,339 (96.2%) 335,503 (92.8%) 333,132 (92.2%)
South Central 469,322 469,322 (100.0%) 467,804 (99.7%) 466,069 (99.3%)
South East Coast 388,040 369,537 (95.2%) 362,703 (98.2%) 362,676 (98.1%)
South West 357,656 353,201 (98.8%) 337,712 (95.6%) 337,711 (95.6%)
Wales 267,513 242,972 (90.8%) 240,679 (99.1%) 225,442 (92.8%)
West Midlands 333,920 333,920 (100.0%) 316,876 (94.9%) 303,968 (91.0%)
Yorkshire & Humber 81,111 63,283 (78.0%) 63,260 (100.0%) 61,119 (96.6%)
Total 3,186,629 3,045,033 (95.6%) 2,916,652 (95.8%) 2,882,229 (94.7%)
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Comparison between the THIN population and the overall
population
Additional file 2 shows the results of the comparison
between the observed levels of the linked measurements
among the THIN population and those expected among
the wider population of England and Wales. Overall,
the patterns are very similar, with the most marked dif-
ferences largely restricted to the Yorkshire & Humber
SHA, which has the both smallest number of participating
practices and the smallest patient population. In particular,
this region exhibits comparatively restricted ranges of
exposures to arsenic, chromium, iron, manganese, and
phosphorus.
Discussion
Key findings
By linking, at postcode level, the G-BASE and THIN data-
bases, we were able to obtain residential soil element levels
for patients at 95% of English and Welsh practices, with
complete geochemical data being available for 92% of
patients within those practices. The levels associated
with patients in the THIN database are in line with expec-
tations based on the known population distributions in
England and Wales, except in areas where there are few
THIN practices.
Strengths and limitations
To our knowledge, the new linked resource is unique,
providing unprecedented population size and statistical
power to study the effects of elements in soil on human
health. The data provide comprehensive, prospective
recording of health outcomes across a population of over
6 million individuals offering, in principle, the potential to
study the effects (whether adverse or beneficial) of any soil
constituent present in the linked dataset on the risk of any
medical condition diagnosed by or reported to primary
care practitioners.
The additional health care and lifestyle details recorded
in EMRs provide us with the ability to adjust for a wide
range of potential confounding factors which may cluster
geographically, as do the prior linkages of the THIN data-
base to measures of area-level socioeconomic status, air
pollution, and land use. The wide range of soil constituent
measures we have linked will permit adjustment for the
presence of other elements which may also modify the risk
of outcomes of interest, and enable us to assess the extent
of effect modification due to the presence of elements
which may affect bioavailability (as in the case of iron and
arsenic) [13].
The similarity of the soil constituent exposure levels
observed among THIN patients to those that would be
expected in the wider population suggests that studies
using the linked resource are likely to produce generalizable
results. Previous validation studies of the THIN
database indicate that participants are representative of
the population at large in terms of a range of sociode-
mographic measures [36].
There are a number of limitations that may affect the
utility of the linked database in practice. The sampling
resolution of the surveys in G-BASE may conceal focal
areas of high variability in soil constituents. Local hetero-
geneity is generally greater in urban areas, but this is
superimposed upon systemically increased concentrations
associated with the impact of urbanisation for elements
such as lead and copper [37, 38]. In urban areas, where
the THIN population is concentrated, sampling density is
high (4 per km2) and work carried out during the comple-
tion planning for G-BASE suggests that improvements in
estimate precision above the 1 per 2 km2 level may be
relatively small [39], although this will vary from element
to element.
Uncertainties always exist in the interpolation of values
between points of measured concentration to make predic-
tions at unsampled locations. We used the inverse distance
weighting method as it is a relatively straightforward and
widely understood approach that produces estimates
primarily determined by the closest available sample
site. Point estimates at the postcode centroid (rather
than an alternative such as an average of all points within
a postcode) were considered sufficient as UK postcode
areas are small (especially relative to the distance between
sampling sites): in urban areas each typically represents a
small section of a street, or even a single large apartment
building) and contains an average of 15 (range 1–100) in-
dividual mail delivery addresses [40]. More sophisticated
techniques (such as those based on machine learning)
which incorporate information from additional mapping
layers have been shown to improve precision in subsets of
the G-BASE data [41], however this is an ongoing area of
research and such methods have not yet been applied or
validated across the full survey area.
We cannot be certain that the presence of raised levels
of a contaminant in the soil in the area where each patient
lives directly translates into increased exposure among
those patients; where patients work a long distance from
home, consume little locally-produced produce, seldom
engage in outdoor activities such as sports or gardening,
or live in focal areas of severe contamination, the true
exposure level may be markedly different. The presence of
a substantial number of such individuals in the THIN
population would tend to introduce random error. This
would typically manifest as a null bias, so whilst it is
unlikely to lead to the false identification of an increased
risk, the magnitude of a true risk might be underestimated.
The large size of the THIN population (and concomitant
statistical power) will reduce the impact of such bias on
our ability to detect raised risks, even in cases where we
are unable to accurately quantify them.
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The participation rate among practices in the Yorkshire
and Humber SHA was low, which may restrict our ability
to draw inferences about the risks experienced by patients
in this area. In addition, there is a known bias towards
arable land within the NSI(XRFS) sample collection
areas (the survey was initially carried out to help assess
agricultural potential). This issue primarily affects West
Wales, where known examples of industrial land con-
tamination are not detectable in the NSI(XRFS) dataset
[37, 42]. We are unable to distinguish between different
compound forms of the elements included in the linkage,
which may be problematic where toxicity or effects on
bioavailability differ [43]. For example, different forms of
iron are known to differentially affect the bioavailability of
arsenic in soils [13]. It is likely, however, to be possible to
at least partially adjust for this at area level; whilst we do
not know the exact locations of patients or practices in
the linked dataset, we do know to which Strategic Health
Authority area each practice belongs, and the ratios
between ironstones and other mineral forms of iron differ
substantially between these areas [44].
Whilst the THIN data are longitudinal, the G-BASE
data are (although collected over an extended period)
effectively cross-sectional, and the linkage has been carried
out at a single point in time. The exposure levels assigned
to each individual may not, therefore, be representative
over the entire duration of follow-up. Previous research
suggests that levels of most of the soil constituents
included in the linkage are driven by (generally slow)
geological processes and that levels are relatively stable
over time, except in areas and for elements where there are
significant ongoing inputs from industrial or agricultural
activities [45].
The linked measures are unlikely to accurately re-
flect long-term exposure for patients who have only
been registered for a short time, however it should be
possible to address this issue by carrying out sensitivity
analyses restricted to patients who have been continuously
registered for an extended period. In addition, THIN is up-
dated quarterly, so the duration of follow-up available for
the patients included in the linkage will increase over time.
Movement of patients away from (and registration of new
participants into) participating practices will, over time,
reduce the proportion of patients for whom soil measures
are available, requiring the linkage to be repeated. The
patients who leave the database will be more likely to be
those who are in highly mobile sociodemographic groups,
somewhat reducing the demographic representativeness of
the linked population, but at the same time preferentially
removing those for whom point estimates of exposure are
least likely to reflect lifetime exposure.
When linking geospatial and medical datasets there is,
in each case, a need to make compromises in order to
preserve patient confidentiality. The THIN/G-BASE
linkage demonstrates a viable approach that provides high
quality, individual-level data on a very large number of
patients at the cost of limiting our knowledge of patient
locations and the number of geochemical variables we
were able to link (to avoid producing unique combinations
which would make postcodes and patients readily identifi-
able). It is unlikely that linkages providing spatial informa-
tion in sufficient detail for risk mapping and GIS analysis,
or that incorporate richer information about soils (e.g.,
more constituents, or details of other soil characteristics
that may influence exposure or bioavailability) would
receive ethical approval in most jurisdictions unless
either explicit patient consent was obtained (limiting the
feasibility of assembling a large research population), or
summary data on population health was used in place of
individual patient records. This situation may improve in
the near future, however, as emerging techniques for
secure multi-party statistical analysis [46] may enable
multiple data-holders to carry out rich joint analyses
without explicitly linking or sharing their datasets with
one another and creating confidentiality concerns in
the process.
Arrangements for access
Given the wide potential scope for studies using the
linked database, it is our hope that external re-
searchers will make use of it in their research and we
have put in place a process to enable wider access.
Both the THIN and G-BASE components of the
linked data are subject to licensing restrictions, and
ethical approval is required from the THIN Scientific
Research Committee before data extracts can be made
available. Parties interested in obtaining data for
research projects should contact IQVIA (https://
www.iqvia.com/locations/uk-and-ireland/thin) in the
first instance.
Conclusions
The linkage of millions of primary care electronic medical
records of patients throughout England and Wales to
individual-level estimates of residential soil element ex-
posure opens new avenues for research in environmental
public health, providing a cohort with considerable
statistical power to investigate even minor effects across
an extremely wide range of health outcomes. Our findings
suggest that, with appropriate adjustment, results should
be generalizable to and representative of the wider English
and Welsh population.
Additional files
Additional file 1: Maps of soil element levels by United Kingdom
Strategic Health Authority area. Contains Ordnance Survey data © Crown
Copyright and database rights [2015]. (DOCX 33519 kb)
Gibson et al. Population Health Metrics  (2018) 16:12 Page 7 of 9
Additional file 2: Observed range of concentrations of 15 linked
constituent elements in the residential soils of patients enrolled in The
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distributions. Boxes indicate interquartile ranges, midlines indicate
median values and whiskers are drawn to the upper and lower adjacent
values. (PDF 87 kb)
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